FI67221C - Foerfarande foer framstaellning av farmakologiskt aktiva tiadiazol- och oxadiazoltetrahydroisokinolinfoereningar - Google Patents
Foerfarande foer framstaellning av farmakologiskt aktiva tiadiazol- och oxadiazoltetrahydroisokinolinfoereningar Download PDFInfo
- Publication number
- FI67221C FI67221C FI802112A FI802112A FI67221C FI 67221 C FI67221 C FI 67221C FI 802112 A FI802112 A FI 802112A FI 802112 A FI802112 A FI 802112A FI 67221 C FI67221 C FI 67221C
- Authority
- FI
- Finland
- Prior art keywords
- tetrahydroisoquinoline
- acetyl
- thiadiazole
- amino
- hydrochloric acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5434379A | 1979-07-02 | 1979-07-02 | |
| US5434379 | 1979-07-02 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI802112A FI802112A (fi) | 1981-01-03 |
| FI67221B FI67221B (fi) | 1984-10-31 |
| FI67221C true FI67221C (fi) | 1985-02-11 |
Family
ID=21990408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI802112A FI67221C (fi) | 1979-07-02 | 1980-07-01 | Foerfarande foer framstaellning av farmakologiskt aktiva tiadiazol- och oxadiazoltetrahydroisokinolinfoereningar |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0023761B1 (ko) |
| JP (1) | JPS5610192A (ko) |
| KR (1) | KR840000396B1 (ko) |
| AR (1) | AR225925A1 (ko) |
| AT (1) | ATE6515T1 (ko) |
| AU (1) | AU531641B2 (ko) |
| BG (1) | BG51250A3 (ko) |
| CA (1) | CA1129415A (ko) |
| CS (1) | CS215064B2 (ko) |
| DD (1) | DD151750A5 (ko) |
| DE (1) | DE3066826D1 (ko) |
| DK (1) | DK151029C (ko) |
| ES (1) | ES8105736A1 (ko) |
| FI (1) | FI67221C (ko) |
| GR (1) | GR69206B (ko) |
| HU (1) | HU179382B (ko) |
| IE (1) | IE50290B1 (ko) |
| IL (1) | IL60426A (ko) |
| IN (1) | IN160542B (ko) |
| MX (1) | MX6317E (ko) |
| NO (1) | NO801951L (ko) |
| NZ (1) | NZ194156A (ko) |
| PH (1) | PH17042A (ko) |
| PL (2) | PL230619A1 (ko) |
| PT (1) | PT71458A (ko) |
| RO (1) | RO79707A (ko) |
| SU (1) | SU1072809A3 (ko) |
| YU (1) | YU171180A (ko) |
| ZA (1) | ZA802987B (ko) |
| ZW (1) | ZW14680A1 (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4352809A (en) * | 1981-09-04 | 1982-10-05 | Smithkline Corporation | Method of producing alpha2 antagonism |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3988339A (en) * | 1974-02-08 | 1976-10-26 | Smithkline Corporation | Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase |
| US3939164A (en) * | 1974-02-08 | 1976-02-17 | Smithkline Corporation | 7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds |
-
1980
- 1980-05-20 ZA ZA00802987A patent/ZA802987B/xx unknown
- 1980-06-25 CS CS804525A patent/CS215064B2/cs unknown
- 1980-06-25 CA CA354,710A patent/CA1129415A/en not_active Expired
- 1980-06-25 JP JP8720980A patent/JPS5610192A/ja active Pending
- 1980-06-25 PH PH24191A patent/PH17042A/en unknown
- 1980-06-26 AT AT80302140T patent/ATE6515T1/de not_active IP Right Cessation
- 1980-06-26 AU AU59677/80A patent/AU531641B2/en not_active Ceased
- 1980-06-26 DK DK274280A patent/DK151029C/da not_active IP Right Cessation
- 1980-06-26 IN IN485/DEL/80A patent/IN160542B/en unknown
- 1980-06-26 PT PT71458A patent/PT71458A/pt unknown
- 1980-06-26 DE DE8080302140T patent/DE3066826D1/de not_active Expired
- 1980-06-26 EP EP80302140A patent/EP0023761B1/en not_active Expired
- 1980-06-26 NZ NZ194156A patent/NZ194156A/xx unknown
- 1980-06-27 NO NO801951A patent/NO801951L/no unknown
- 1980-06-27 ZW ZW146/80A patent/ZW14680A1/xx unknown
- 1980-06-27 IL IL60426A patent/IL60426A/xx unknown
- 1980-06-28 KR KR1019800002551A patent/KR840000396B1/ko active
- 1980-06-30 AR AR281587A patent/AR225925A1/es active
- 1980-06-30 DD DD80222268A patent/DD151750A5/de unknown
- 1980-06-30 IE IE1352/80A patent/IE50290B1/en unknown
- 1980-06-30 RO RO80101552A patent/RO79707A/ro unknown
- 1980-07-01 PL PL23061980A patent/PL230619A1/xx unknown
- 1980-07-01 BG BG048339A patent/BG51250A3/xx unknown
- 1980-07-01 PL PL1980225377A patent/PL127098B1/pl unknown
- 1980-07-01 HU HU80801631A patent/HU179382B/hu unknown
- 1980-07-01 SU SU802942953A patent/SU1072809A3/ru active
- 1980-07-01 FI FI802112A patent/FI67221C/fi not_active IP Right Cessation
- 1980-07-01 ES ES492971A patent/ES8105736A1/es not_active Expired
- 1980-07-01 YU YU01711/80A patent/YU171180A/xx unknown
- 1980-07-01 GR GR62330A patent/GR69206B/el unknown
- 1980-07-02 MX MX808900U patent/MX6317E/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1129093B1 (en) | Pyrazolopyrimidinone derivatives for the treatment of impotence | |
| FI79846B (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla heteroaromatiska aminderivat. | |
| Bruno et al. | New polycyclic pyrimidine derivatives with antiplatelet in vitro activity: synthesis and pharmacological screening | |
| EP0521768A1 (fr) | Nouveaux dérivés de triazolopyrimidine antagonistes des récepteurs à l'angiotensine II; leurs procédés de préparation, compositions pharmaceutiques les contenant | |
| PL91610B1 (ko) | ||
| US4128666A (en) | 4 AND 5-Halo substituted 2-indanamine compounds | |
| FI67221C (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva tiadiazol- och oxadiazoltetrahydroisokinolinfoereningar | |
| PL144341B1 (en) | Method of obtaining new heterocyclic compounds | |
| US4352809A (en) | Method of producing alpha2 antagonism | |
| FI68399B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 2-amino-3-nitropyrrolderivat | |
| FI64939B (fi) | Foerfarande foer framstaellning av en 10,11-dihydro-5h-dibenso(a,d)cyklohepten-5,10-imin | |
| NZ222805A (en) | Triazine derivatives and pharmaceutical compositions | |
| US4192888A (en) | Pharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferase | |
| US4093725A (en) | (3-Alkylamino-2-hydroxypropoxy)-1-hydrazinophthalazines | |
| US4228170A (en) | 7- and/or 8-Sulfur substituted 1,2,3,4-tetrahydroisoquinoline compounds | |
| US4258049A (en) | Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines | |
| US4539402A (en) | Quinazolinone derivatives | |
| US4242346A (en) | Bis-2N-alkylene tetrahydroisoquinoline compounds | |
| US4272531A (en) | 3,3'-Bis-methylene-1,3-benzo-thiazine compounds | |
| US3560512A (en) | 3-substituted-2,1-benzisothiazoline-2,2-dioxides | |
| US4576954A (en) | Anti-rheumatic 5-(substituted amino)-1,2-dithiol-3-one compounds and their use | |
| CS228929B2 (cs) | Způsob výroby ve vodě rozpustných solí N-(2-pyridyl)-2-methyl-4-hydroxy-2H-l,2-benzothiazin-3-karboxamid-l,l-dioxidu | |
| Bolhofer et al. | Inhibition of gastric acid secretion by 1, 8-naphthyridin-2 (1H)-ones | |
| EP0172692B1 (en) | Hexahydroindolizine compounds, pharmaceutical compositions and methods and intermediates | |
| FI89363C (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla tieno(3',4'-4,5)imidazo(2,1-b)tiazolderivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: SMITHKLINE BECKMAN CORPORATION |